<![CDATA[
<p style="text-align: start;"><span style="color: #000000;" data-ke-size="size14">본 원에서는 <span style="color: #ee2323;"><b>NEJM을 온라인으로 구독 중입니다.</b></span></span></p><p style="text-align: start;"> </p><p style="text-align: start;"><span data-ke-size="size14"><span style="color: #000000;"><b><span style="background-color: #f3c000;"><a style="color: #0070d1;" href="https://www.nejm.org/" target="_blank" class="ke-link">NEJM</a></span> ☞ <a href="https://www.nejm.org/" target="_top" class="ke-link">https://www.nejm.org/</a></b></span></span></p><p style="text-align: start;"><span data-ke-size="size14"><span style="color: #ff00dd;"><b>PUB  </b></span><span style="color: #000000; background-color: #ffffff;">1990년 ~ 최근<br><br></span></span></p><p style="text-align: start;"><span data-ke-size="size14"><span style="color: #000000; background-color: #ffffff;"><b><span style="color: #006dd7;">NEJM AI</span><span style="color: #000000;"> ☞</span> <a href="https://ai.nejm.org/" target="_top" class="ke-link">https://ai.nejm.org/</a></b></span></span></p><div class="figure-img" data-ke-type="image" data-ke-style="alignLeft" data-ke-mobilestyle="widthOrigin" data-link="https://ai.nejm.org/" data-link-newwindow="_blank"><a href="https://ai.nejm.org/" target="_blank" class="ke-link"><img src="https://t1.daumcdn.net/cafeattach/1D3AW/58e254413f16e91d8bdeb55ee22b5a2b1cbe95cf" width="73" height="41" data-img-src="https://t1.daumcdn.net/cafeattach/1D3AW/58e254413f16e91d8bdeb55ee22b5a2b1cbe95cf" data-origin-width="125" data-origin-height="70"></a></div><p style="text-align: start;"><span data-ke-size="size14"><span style="color: #000000; background-color: #ffffff;"><b><span style="color: #000000; background-color: #ffffff;">※ NEJM AI에 대한 궁금증 ☞ <a href="https://cafe.daum.net/medlib0457/QvKv/348" target="_top" class="ke-link">https://cafe.daum.net/medlib0457/QvKv/348</a></span></b></span></span></p><p style="text-align: start;"> </p><p style="text-align: start;"><span style="color: #000000;" data-ke-size="size14"><b>※ 매년 이용 통계를 참고하여 구독을 유지 혹은 유보할 수 있습니다.</b></span></p><p style="text-align: start;"> </p><p style="text-align: start;"><span style="color: #000000;" data-ke-size="size14"><b>※ 위의 URL을 클릭해서 유료인 논문은 서지 사항을 복사해 도서실로 신청해 주시기 바랍니다.</b></span></p><p style="text-align: start;"><span style="color: #000000;" data-ke-size="size14">   외국학술지지원센터를 통해 신청과 동시에 바로 무료로 제공해 드립니다.</span></p><p style="text-align: start;"> </p><p style="text-align: start;"><span data-ke-size="size14"><a href="http://www.riss.kr/search/detail/DBholdingsInfo.do?s_control_no=dcf8518ff0f5a2d0ffe0bdc3ef48d419&lib_code=cdd9c08442411232&inside_outside=0" target="_top" class="ke-link">http://www.riss.kr/search/detail/DBholdingsInfo.do?s_control_no=dcf8518ff0f5a2d0ffe0bdc3ef48d419&lib_code=cdd9c08442411232&inside_outside=0</a></span></p><p style="text-align: start;"><span style="color: #000000;" data-ke-size="size14"><b>1930년 ~ 최근호, 신청 당일 무료 제공(DMC Email을 사용해 서지사항 도서실로 발송)<br><br></b></span></p><p style="text-align: start;"><span data-ke-size="size14"><a href="http://www.riss.kr/search/detail/DBholdingsInfo.do?s_control_no=dcf8518ff0f5a2d0ffe0bdc3ef48d419&lib_code=2e651599dfec7a91&inside_outside=0" target="_top" class="ke-link">http://www.riss.kr/search/detail/DBholdingsInfo.do?s_control_no=dcf8518ff0f5a2d0ffe0bdc3ef48d419&lib_code=2e651599dfec7a91&inside_outside=0</a></span></p><p style="text-align: start;"><span data-ke-size="size14"><span style="color: #000000;"><b>1954년 ~ 2016년, 신청 당일 무료 제공(DMC Email을 사용해 서지사항 도서실로 발송)</b></span></span></p><div class="figure-img" data-ke-type="image" data-ke-style="alignLeft" data-ke-mobilestyle="widthOrigin"><img src="https://t1.daumcdn.net/cafeattach/1D3AW/617e301444200aaeebe1863a91d0cb3af2ba4530" class="txc-image" data-img-src="https://t1.daumcdn.net/cafeattach/1D3AW/617e301444200aaeebe1863a91d0cb3af2ba4530" data-origin-width="238" data-origin-height="16"></div><p style="text-align: start;"><span data-ke-size="size14"><b><span style="color: #ee2323;">※ 아래 논문들은 모두 무료로 제공됩니다. 마우스를 해당 타이틀로 가져가 클릭하면 해당 논문으로 바로 이동합니다.<br>    <a href="https://www.nejm.org" target="_top" class="ke-link">https://www.nejm.org</a> 방<span style="color: #ee2323;">문하면 더 많은 논문을 직접 이용할 수 있습니다.</span></span></b></span></p><p style="text-align: start;"> </p><p style="text-align: start;"><span style="color: #8a3db6;"><b><span data-ke-size="size14"> Images in Clinical Medicine </span></b></span></p><p style="text-align: start;"> </p><p style="text-align: left;"><span style="color: #006dd7;"><b><span data-ke-size="size14"><a style="color: #006dd7;" href="https://t.n.nejm.org/r/?id=h974959da,83951e5,3adb0d9&cid=DM2361162_Non_Subscriber&bid=-1756800550&p1=U2FsdGVkX18x2YeyHIWtxUFA9%2Flhj0SY78QONMJkHwIcTDFG1CnQEXEIGufjf1p3cD4teHT3hPMkRAGE%2B%2Bvs3mLjNnwUns0%2FV5q6gwTYtZsDu4t221KcYsY74ajTr%2BYj17NBEa6UGLW%2B84LQLnO%2BLeWsOiAvrsM53XbhIRANsaIfMYFamXjBW86r1lhIWVQIM3v2NobqsWxpvuHWkab%2BnQ%3D%3D" target="_blank" class="ke-link">Fabry’s Disease</a></span></b></span></p><p style="text-align: left;"><span data-ke-size="size14">S. Soloway and D. Lister</span></p><p style="text-align: left;"><span data-ke-size="size14">N Engl J Med 2024;391:1038</span></p><p style="text-align: left;"> </p><p style="text-align: left;"><span style="color: #006dd7;"><b><span data-ke-size="size14"><a style="color: #006dd7;" href="https://t.n.nejm.org/r/?id=h974959da,83951e5,3adb0da&cid=DM2361162_Non_Subscriber&bid=-1756800550&p1=U2FsdGVkX18x2YeyHIWtxUFA9%2Flhj0SY78QONMJkHwIcTDFG1CnQEXEIGufjf1p3cD4teHT3hPMkRAGE%2B%2Bvs3mLjNnwUns0%2FV5q6gwTYtZsDu4t221KcYsY74ajTr%2BYj17NBEa6UGLW%2B84LQLnO%2BLeWsOiAvrsM53XbhIRANsaIfMYFamXjBW86r1lhIWVQIM3v2NobqsWxpvuHWkab%2BnQ%3D%3D" target="_blank" class="ke-link">Flail Chest</a></span></b></span></p><p style="text-align: left;"><span data-ke-size="size14">Z. Hu and B. Wang</span></p><p style="text-align: left;"><span data-ke-size="size14">N Engl J Med 2024;391:e22 | Published Online September 14, 2024</span></p><p style="text-align: left;"> </p><p style="text-align: left;"><span style="color: #8a3db6;"><b><span data-ke-size="size14"> Editorials </span></b></span></p><p style="text-align: left;"> </p><p style="text-align: left;"><span style="color: #006dd7;"><b><span data-ke-size="size14"><a style="color: #006dd7;" href="https://t.n.nejm.org/r/?id=h974959da,83951e5,3adb0e0&cid=DM2361162_Non_Subscriber&bid=-1756800550&p1=U2FsdGVkX18x2YeyHIWtxUFA9%2Flhj0SY78QONMJkHwIcTDFG1CnQEXEIGufjf1p3cD4teHT3hPMkRAGE%2B%2Bvs3mLjNnwUns0%2FV5q6gwTYtZsDu4t221KcYsY74ajTr%2BYj17NBEa6UGLW%2B84LQLnO%2BLeWsOiAvrsM53XbhIRANsaIfMYFamXjBW86r1lhIWVQIM3v2NobqsWxpvuHWkab%2BnQ%3D%3D" target="_blank" class="ke-link">NEJM at ESMO — Preoperative Chemoradiotherapy for Resectable Gastric Cancer</a></span></b></span></p><p style="text-align: left;"><span data-ke-size="size14">E.J. Rubin, O.O. Yeku, and S. Morrissey</span></p><p style="text-align: left;"><span data-ke-size="size14">DOI: 10.1056/NEJMe2411487 | September 14, 2024</span></p><p style="text-align: left;"> </p><p style="text-align: left;"><span style="color: #006dd7;"><b><span data-ke-size="size14"><a style="color: #006dd7;" href="https://t.n.nejm.org/r/?id=h974959da,83951e5,3adb0e1&cid=DM2361162_Non_Subscriber&bid=-1756800550&p1=U2FsdGVkX18x2YeyHIWtxUFA9%2Flhj0SY78QONMJkHwIcTDFG1CnQEXEIGufjf1p3cD4teHT3hPMkRAGE%2B%2Bvs3mLjNnwUns0%2FV5q6gwTYtZsDu4t221KcYsY74ajTr%2BYj17NBEa6UGLW%2B84LQLnO%2BLeWsOiAvrsM53XbhIRANsaIfMYFamXjBW86r1lhIWVQIM3v2NobqsWxpvuHWkab%2BnQ%3D%3D" target="_blank" class="ke-link">NEJM at ESMO — Pembrolizumab in HER2+ Gastric Cancer</a></span></b></span></p><p style="text-align: left;"><span data-ke-size="size14">E.J. Rubin, O.O. Yeku, and S. Morrissey</span></p><p style="text-align: left;"><span data-ke-size="size14">DOI: 10.1056/NEJMe2411493 | September 14, 2024</span></p><p style="text-align: left;"> </p><p style="text-align: left;"><span style="color: #006dd7;"><b><span data-ke-size="size14"><a style="color: #006dd7;" href="https://t.n.nejm.org/r/?id=h974959da,83951e5,3adb0e2&cid=DM2361162_Non_Subscriber&bid=-1756800550&p1=U2FsdGVkX18x2YeyHIWtxUFA9%2Flhj0SY78QONMJkHwIcTDFG1CnQEXEIGufjf1p3cD4teHT3hPMkRAGE%2B%2Bvs3mLjNnwUns0%2FV5q6gwTYtZsDu4t221KcYsY74ajTr%2BYj17NBEa6UGLW%2B84LQLnO%2BLeWsOiAvrsM53XbhIRANsaIfMYFamXjBW86r1lhIWVQIM3v2NobqsWxpvuHWkab%2BnQ%3D%3D" target="_blank" class="ke-link">NEJM at ESMO — Ponsegromab in Cancer Cachexia</a></span></b></span></p><p style="text-align: left;"><span data-ke-size="size14">E.J. Rubin, O.O. Yeku, and S. Morrissey</span></p><p style="text-align: left;"><span data-ke-size="size14">DOI: 10.1056/NEJMe2411491 | September 14, 2024</span></p><p style="text-align: left;"> </p><p style="text-align: left;"><span style="color: #006dd7;"><b><span data-ke-size="size14"><a style="color: #006dd7;" href="https://t.n.nejm.org/r/?id=h974959da,83951e5,3adb0e3&cid=DM2361162_Non_Subscriber&bid=-1756800550&p1=U2FsdGVkX18x2YeyHIWtxUFA9%2Flhj0SY78QONMJkHwIcTDFG1CnQEXEIGufjf1p3cD4teHT3hPMkRAGE%2B%2Bvs3mLjNnwUns0%2FV5q6gwTYtZsDu4t221KcYsY74ajTr%2BYj17NBEa6UGLW%2B84LQLnO%2BLeWsOiAvrsM53XbhIRANsaIfMYFamXjBW86r1lhIWVQIM3v2NobqsWxpvuHWkab%2BnQ%3D%3D" target="_blank" class="ke-link">NEJM at ESMO — Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma</a></span></b></span></p><p style="text-align: left;"><span data-ke-size="size14">E.J. Rubin, O.O. Yeku, and S. Morrissey</span></p><p style="text-align: left;"><span data-ke-size="size14">DOI: 10.1056/NEJMe2411485 | September 15, 2024</span></p><p style="text-align: left;"> </p><p style="text-align: left;"><span style="color: #006dd7;"><b><span data-ke-size="size14"><a style="color: #006dd7;" href="https://t.n.nejm.org/r/?id=h974959da,83951e5,3adb0e4&cid=DM2361162_Non_Subscriber&bid=-1756800550&p1=U2FsdGVkX18x2YeyHIWtxUFA9%2Flhj0SY78QONMJkHwIcTDFG1CnQEXEIGufjf1p3cD4teHT3hPMkRAGE%2B%2Bvs3mLjNnwUns0%2FV5q6gwTYtZsDu4t221KcYsY74ajTr%2BYj17NBEa6UGLW%2B84LQLnO%2BLeWsOiAvrsM53XbhIRANsaIfMYFamXjBW86r1lhIWVQIM3v2NobqsWxpvuHWkab%2BnQ%3D%3D" target="_blank" class="ke-link">NEJM at ESMO — Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer</a></span></b></span></p><p style="text-align: left;"><span data-ke-size="size14">E.J. Rubin, O.O. Yeku, and S. Morrissey</span></p><p style="text-align: left;"><span data-ke-size="size14">DOI: 10.1056/NEJMe2411488 | September 15, 2024</span></p><p style="text-align: left;"> </p><p style="text-align: left;"><span style="color: #006dd7;"><b><span data-ke-size="size14"><a style="color: #006dd7;" href="https://t.n.nejm.org/r/?id=h974959da,83951e5,3adb0e5&cid=DM2361162_Non_Subscriber&bid=-1756800550&p1=U2FsdGVkX18x2YeyHIWtxUFA9%2Flhj0SY78QONMJkHwIcTDFG1CnQEXEIGufjf1p3cD4teHT3hPMkRAGE%2B%2Bvs3mLjNnwUns0%2FV5q6gwTYtZsDu4t221KcYsY74ajTr%2BYj17NBEa6UGLW%2B84LQLnO%2BLeWsOiAvrsM53XbhIRANsaIfMYFamXjBW86r1lhIWVQIM3v2NobqsWxpvuHWkab%2BnQ%3D%3D" target="_blank" class="ke-link">NEJM at ESMO — Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma</a></span></b></span></p><p style="text-align: left;"><span data-ke-size="size14">E.J. Rubin, O.O. Yeku, and S. Morrissey</span></p><p style="text-align: left;"><span data-ke-size="size14">DOI: 10.1056/NEJMe2411489 | September 15, 2024</span></p><p style="text-align: left;"> </p><p style="text-align: left;"><span style="color: #006dd7;"><b><span data-ke-size="size14"><a style="color: #006dd7;" href="https://t.n.nejm.org/r/?id=h974959da,83951e5,3adb0e6&cid=DM2361162_Non_Subscriber&bid=-1756800550&p1=U2FsdGVkX18x2YeyHIWtxUFA9%2Flhj0SY78QONMJkHwIcTDFG1CnQEXEIGufjf1p3cD4teHT3hPMkRAGE%2B%2Bvs3mLjNnwUns0%2FV5q6gwTYtZsDu4t221KcYsY74ajTr%2BYj17NBEa6UGLW%2B84LQLnO%2BLeWsOiAvrsM53XbhIRANsaIfMYFamXjBW86r1lhIWVQIM3v2NobqsWxpvuHWkab%2BnQ%3D%3D" target="_blank" class="ke-link">NEJM at ESMO — Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer</a></span></b></span></p><p style="text-align: left;"><span data-ke-size="size14">E.J. Rubin, O.O. Yeku, and S. Morrissey</span></p><p style="text-align: left;"><span data-ke-size="size14">DOI: 10.1056/NEJMe2411490 | September 15, 2024</span></p><p style="text-align: left;"> </p><p style="text-align: left;"><span style="color: #006dd7;"><b><span data-ke-size="size14"><a style="color: #006dd7;" href="https://t.n.nejm.org/r/?id=h974959da,83951e5,3adb0e7&cid=DM2361162_Non_Subscriber&bid=-1756800550&p1=U2FsdGVkX18x2YeyHIWtxUFA9%2Flhj0SY78QONMJkHwIcTDFG1CnQEXEIGufjf1p3cD4teHT3hPMkRAGE%2B%2Bvs3mLjNnwUns0%2FV5q6gwTYtZsDu4t221KcYsY74ajTr%2BYj17NBEa6UGLW%2B84LQLnO%2BLeWsOiAvrsM53XbhIRANsaIfMYFamXjBW86r1lhIWVQIM3v2NobqsWxpvuHWkab%2BnQ%3D%3D" target="_blank" class="ke-link">NEJM at ESMO — Overall Survival with Pembrolizumab in Early-Stage Triple- Negative Breast Cancer</a></span></b></span></p><p style="text-align: left;"><span data-ke-size="size14">E.J. Rubin, O.O. Yeku, and S. Morrissey</span></p><p style="text-align: left;"><span data-ke-size="size14">DOI: 10.1056/NEJMe2411492 | September 15, 2024</span></p><p style="text-align: left;"> </p><p style="text-align: left;"><span style="color: #006dd7;"><b><span data-ke-size="size14"><a style="color: #006dd7;" href="https://t.n.nejm.org/r/?id=h974959da,83951e5,3adb0e8&cid=DM2361162_Non_Subscriber&bid=-1756800550&p1=U2FsdGVkX18x2YeyHIWtxUFA9%2Flhj0SY78QONMJkHwIcTDFG1CnQEXEIGufjf1p3cD4teHT3hPMkRAGE%2B%2Bvs3mLjNnwUns0%2FV5q6gwTYtZsDu4t221KcYsY74ajTr%2BYj17NBEa6UGLW%2B84LQLnO%2BLeWsOiAvrsM53XbhIRANsaIfMYFamXjBW86r1lhIWVQIM3v2NobqsWxpvuHWkab%2BnQ%3D%3D" target="_blank" class="ke-link">NEJM at ESMO — Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma</a></span></b></span></p><p style="text-align: left;"><span data-ke-size="size14">E.J. Rubin, O.O. Yeku, and S. Morrissey</span></p><p style="text-align: left;"><span data-ke-size="size14">DOI: 10.1056/NEJMe2411494 | September 16, 2024</span></p><p style="text-align: left;"> </p><p style="text-align: left;"><span style="color: #006dd7;"><b><span data-ke-size="size14"><a style="color: #006dd7;" href="https://t.n.nejm.org/r/?id=h974959da,83951e5,3adb0e9&cid=DM2361162_Non_Subscriber&bid=-1756800550&p1=U2FsdGVkX18x2YeyHIWtxUFA9%2Flhj0SY78QONMJkHwIcTDFG1CnQEXEIGufjf1p3cD4teHT3hPMkRAGE%2B%2Bvs3mLjNnwUns0%2FV5q6gwTYtZsDu4t221KcYsY74ajTr%2BYj17NBEa6UGLW%2B84LQLnO%2BLeWsOiAvrsM53XbhIRANsaIfMYFamXjBW86r1lhIWVQIM3v2NobqsWxpvuHWkab%2BnQ%3D%3D" target="_blank" class="ke-link">NEJM at ESMO — Phase 3 Trial of Cabozantinib in Advanced Neuroendocrine Tumors</a></span></b></span></p><p style="text-align: left;"><span data-ke-size="size14">E.J. Rubin, O.O. Yeku, and S. Morrissey</span></p><p style="text-align: left;"><span data-ke-size="size14">DOI: 10.1056/NEJMe2411486 | September 16, 2024</span></p><p> </p><p> </p><div class="figure-img" data-ke-type="image" data-ke-style="alignLeft" data-ke-mobilestyle="widthOrigin" data-link="https://www.dmc.or.kr/" data-link-newwindow="_blank"><a href="https://www.dmc.or.kr/" target="_blank" class="ke-link"><img src="https://t1.daumcdn.net/cafeattach/1D3AW/c826708f72f2661da1255b3d2ad0c44e91a33f5e" data-img-src="https://t1.daumcdn.net/cafeattach/1D3AW/c826708f72f2661da1255b3d2ad0c44e91a33f5e" data-origin-width="90" data-origin-height="84"></a></div>
<!-- -->
]]>
카페 게시글
NEJM
The New England Journal of Medicine, September 19, 2024
꽉이
추천 0
조회 12
24.09.19 16:09
댓글 0
다음검색
